Physician profile
Moises Enghelberg
NPI 1730570896
$2,134.25
in general payments reported to CMS, 2019-2025
18 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $20.53 · 2021: $32.81 · 2022: $171 · 2023: $740 · 2024: $348 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742 · Education: $40.56 · Entertainment: $18.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,742.49 |
| Education | $40.56 |
| Entertainment | $18.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $387.99 | 2021-2023 | Acthar |
| Astellas Pharma US INC | $248.47 | 2023-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $239.76 | 2023-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $194.94 | 2019-2023 | Clareon |
| Abbvie INC. | $162.04 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $155.38 | 2025 | Yutiq, Purified Cortrophin Gel, Iluvien |
| Amgen INC. | $126.43 | 2025 | Tepezza |
| Bausch & Lomb Americas INC. | $119.15 | 2023 | Envista Mx60 Iol |
| Genentech USA, INC. | $103.01 | 2023-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $94.32 | 2022-2025 | Syfovre |
| Glaukos Corporation | $93.13 | 2025 | Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $78.60 | 2019 | |
| Neurotech Pharmaceuticals, INC. | $28.49 | 2025 | |
| Thea Pharma INC. | $24.08 | 2024 | Iyuzeh |
| Tearlab Corp | $21.00 | 2023 | Tearlab Osmolarity System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $20.53 | 2020 | |
| Optos, INC. | $18.89 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rxsight INC | $18.04 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moises Enghelberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.